The Animal Medicine and Veterinary Vaccines Sector – a $22 billion market

As highlighted by Zoetis , the largest global animal healthcare company and latest exhibitor partner to the Vaccine Congress Washington 2015, the animal medicines and veterinary vaccines sector is estimated to represent a global market of $22 billion within the approximate $92 – 102 billion animal health industry.   Additionally between 2011 and 2016, the animal medicines and vaccines sector is …

Pfizer plans Animal-Health Unit IPO

According to Reuters, Pfizer Inc plans to separate its animal health unit into a stand-alone company, hoping to focus more intently on its core pharmaceuticals business.  Pfizer said on Thursday that preparations were under way for a public offering of a minority stake in the new animal health company, which would be called Zoetis. Ian Read, Pfizer's chief executive has …

Download – Implementing cross-protection against #influenza virus infection by intranasal administration of NP- and M- based #vaccine

Discover methods to achieve cross-protection against influenza virus protection from Dr. Chen Ze, Assistant Diretor of SIBP, Head of the Laboratory of Virus & Vaccine Shanghai Institute of Biological Products, China. Dr. Chen Ze is currently a Professor of Shanghai Institute of Biological Products (SIBP) and a part-time Chair Professor of College of Life Science, Hunan Normal University. He is …

Download: Uncovering the public health benefits of quadrivalent live attenuated influenza vaccines

Discover public health benefits of quadrivalent live attenuated influenza vaccines, as presented by Filip Dubovsky, Vice Presideent Clinical Development, Therapeutic Area Head, Vaccines, MedImmune, United States. Dr. Filip Dubovsky joined MedImmune in August 2006 as director, clinical development and was named vicee president, clinical development, and global clinical therapeutic head, vaccines in July 2008. In this capacity, he leads the …